178
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Alcohol use disorder pharmacotherapy and treatment in primary care (ADaPT-PC) trial: Impact on identified barriers to implementation

, PhDORCID Icon, , PhD MPH, , MS, , PhD MPH, , MD, , MD, , MD, , MD, , PhD, , PhD & , PhD show all

References

  • Han B, Jones CM, Einstein EB, Powell PA, Compton WM. Use of medications for alcohol use disorder in the US: results from the 2019 National Survey on Drug use and Health. JAMA Psychiatry. 2021;78(8):922–924.
  • Management of Substance Use Disorders Work Group. VA/DoD clinical practice guideline for the management of substance use disorders (version 4.0). Washington, DC: Department of Veterans Affairs, Department of Defense; 2021.
  • Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25(9):1335–1341.
  • Bouza C, Magro A, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004;99:811–828.
  • Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295(17):2003–2017.
  • Rosner S, Hackl-Herwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2011;9:CD004332.
  • Joudrey PJ, Kladney M, Cunningham CO, Bachhuber MA. Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD). Addict Sci Clin Pract. 2019;14(1):19.
  • Williams EC, Chen JA, Frost MC, et al. Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: overall and relative to non-transgender patients. JSAT. 2021;131:108565.
  • Harris AH, Kivlahan D, Bow T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010; 61(4):392–398.
  • Del Re AC, Gordon AJ, Lembke A, Harris AH. Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addict Sci Clin Pract. 2013;8:12.
  • Iheanacho T, Issa M, Marienfeld C, Rosenheck R. Use of naltrexone for alcohol use disorders in the Veterans’ Health Administration: a national study. Drug Alcohol Depend. 2013;132(1–2):122–126.
  • Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AHS. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–157.
  • Spithoff S, Kahan M. Paradigm shift: moving the management of alcohol use disorders from specialized care to primary care. Can Family Phys. 2015;61(6):491–493.
  • Rehm J, Anderson P, Manthey J, et al. Alcohol use disorders in primary health care: what do we know and where do we go? Alcohol Alcohol. 2016; 51(4):422–427.
  • Ornstein SM, Miller PM, Wessell AM, Jenkins RG, Nemeth LS, Nietert PJ. Integration and sustainability of alcohol screening, brief intervention, and pharmacotherapy in primary care settings. J Stud Alcohol Drugs. 2013;74(4):598–604.
  • Saitz R, Cheng DM, Winter M, et al. Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA 2013;310(11):1156–1167.
  • Oslin DW, Lynch KG, Maisto SA, et al. A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment. J Gen Intern Med. 2014;29(1):162–168.
  • Harris AHS, Bowe T, Hagedorn H, et al. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness. Addict Sci Clin Pract. 2016;11(1):15.
  • Bradley KA, Bobb JF, Ludman EJ, et al. Alcohol-related nurse care management in primary care: a randomized clinical trial. JAMA Intern Med. 2018;178(5):613–621.
  • Hagedorn H, Brown R, Dawes M, et al. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC. Implement Sci. 2016;11:64.
  • Harris AHS, Brown R, Dawes M, Dieperink , et al. Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration. J Subst Abuse Treat. 2017;82:107–112.
  • Hagedorn HJ, Wisdom JP, Gerould H, et al. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes. Addict Sci Clin Pract. 2019;14(1):24.
  • Hagedorn H, Kenny M, Gordon AJ, et al. Advancing pharmacological treatments for opioid use disorder (ADAPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for Veterans with opioid use disorders in low-performing facilities. Addict Sci Clin Pract. 2018;13(1):25.
  • Gustavson AM, Wisdom JP, Kenny ME, et al. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implement Sci Commun. 2021;2(1):20.
  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(50):50.
  • Miles MB, Huberman MA, Saldana J. Qualitative data analysis: a methods sourcebook. 3rd ed. Thousand Oaks, CA: Sage Publications; 2014.
  • Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research. Implement Sci. 2013;8(51):51.
  • CFIR Technical Assistance Website. http://www.cfirguide.org. Accessed March 24, 2016.
  • Gustavson AM, Kenny ME, Wisdom JP, et al. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addict Sci Clin Pract. 2021;16(1):51.
  • Centers for Disease Control and Prevention. Alcohol and Public Health: Alcohol related disease impact (ARDI). Annual average for United States 2011–2015 Alcohol-Attributable deaths due to excessive alcohol use, all ages. https://nccd.cdc.gov/DPH_+ARDI/Default/Default.aspx

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.